News Bulletin
Thursday, January 08, 2026
Evening Edition
Economic Numbers:
|
Time |
Event |
Actual |
Forecast |
Previous |
|
5:30 |
Challenger
Job Cuts (YoY) |
-8.30% |
|
23.50% |
|
7:30 |
Challenger
Job Cuts (Dec) |
35.553K |
|
71.321K |
|
8:30 |
Continuing
Jobless Claims |
1,914K |
1,900K |
1,858K |
|
8:30 |
Exports (Oct) |
302.00B |
|
289.30B |
|
8:30 |
Imports (Oct) |
331.40B |
|
342.10B |
|
8:30 |
Initial
Jobless Claims |
208K |
213K |
200K |
|
8:30 |
Jobless
Claims 4-Week Avg. |
211.75K |
|
219.00K |
|
8:30 |
Nonfarm
Productivity (QoQ) (Q3) |
4.90% |
4.90% |
4.10% |
|
8:30 |
Trade Balance
(Oct) |
-29.40B |
-58.10B |
-48.10B |
|
8:30 |
Unit Labor
Costs (QoQ) (Q3)
|
-1.90% |
0.00% |
-2.90% |
|
10:30 |
Natural Gas
Storage |
-119B |
-109B |
-38B |
|
11:00 |
NY Fed 1-Year
Consumer Inflation Expectations (Dec) |
3.40% |
|
3.20% |
|
12:00 |
Atlanta Fed GDPNow (Q4) |
5.40% |
2.70% |
2.70% |
|
15:00 |
Consumer
Credit (Nov) |
4.23B |
10.10B |
9.24B |
Indices
|
|
CLOSE |
50 DMA |
200 DMA |
|
DJIA |
49,266.11 |
47,748.52 |
44,684.95 |
|
NASDAQ |
23,480.02 |
23,281.69 |
20,970.73 |
|
S&P 500 |
6,921.46 |
6,816.70 |
6,317.25 |
Earnings Calendar:
(EPS: Earning Per Share / Rev: Revenue / Mkt Cap : market Capital/ BMO :
Before Market Opening /AMC : After Market Close)
|
Company |
EPS |
Forecast |
Revenue |
Forecast |
Market
Cap |
Time |
|
Fast Retailing ADR (FRCOY) |
-- |
0.2601 |
-- |
6.31B |
110.92B |
BMO |
|
Aeon ADR (AONNY) |
-- |
0.009 |
-- |
16.77B |
41.7B |
BMO |
|
Tesco PLC (TSCDY) |
-- |
-- |
-- |
22.93B |
36.07B |
BMO |
|
Seven i ADR (SVNDY) |
-- |
0.1966 |
-- |
15.9B |
34.01B |
BMO |
|
RPM (RPM) |
1.2 |
1.43 |
1.91B |
1.94B |
13.44B |
BMO |
|
TD Synnex (SNX) |
3.83 |
3.73 |
17.38B |
16.93B |
11.99B |
BMO |
|
Acuity Brands (AYI) |
4.69 |
4.58 |
1.14B |
1.14B |
11.28B |
BMO |
|
Commercial Metals (CMC) |
1.84 |
1.56 |
2.12B |
2.06B |
7.85B |
BMO |
|
Sodexo PK (SDXAY) |
-- |
-- |
7.3B |
-- |
7.38B |
BMO |
|
Simply Good Foods (SMPL) |
0.39 |
0.36 |
340.2M |
335.93M |
1.96B |
BMO |
|
Neogen (NEOG) |
0.1 |
0.03 |
224.7M |
208.12M |
1.6B |
BMO |
|
Lindsay (LNN) |
1.54 |
1.53 |
155.8M |
172.42M |
1.26B |
BMO |
|
Helen of Troy Ltd (HELE) |
1.71 |
1.69 |
512.8M |
502.42M |
478.54M |
BMO |
|
Northern Technologies (NTIC) |
0.04 |
0.02 |
23.31M |
20.7M |
83.05M |
BMO |
|
Marks & Spencer Group Plc (MAKSY) |
-- |
-- |
-- |
-- |
9.33B |
|
|
WaFd Inc (WAFD) |
-- |
0.755 |
-- |
192.83M |
2.57B |
|
|
Park Aerospace (PKE) |
-- |
-- |
-- |
-- |
468.98M |
|
|
Lifecore Biomedical (LFCR) |
-- |
-0.16 |
-- |
37.21M |
292.24M |
|
|
Hurco (HURC) |
-- |
-- |
-- |
-- |
98.63M |
|
|
Loop Industries (LOOP) |
-- |
-0.055 |
-- |
875K |
52.85M |
|
|
Brookmount Explorations Inc (BMXI) |
-- |
-- |
-- |
-- |
12.27M |
|
|
Educational Development (EDUC) |
-- |
-- |
-- |
-- |
12.19M |
|
|
WD-40 (WDFC) |
1.28 |
1.45 |
154.4M |
161.2M |
2.74B |
AMC |
|
Greenbrier (GBX) |
1.14 |
0.87 |
-- |
675.25M |
1.66B |
AMC |
|
Aehr Test Systems (AEHR) |
-- |
-0.0287 |
-- |
12.42M |
682.05M |
AMC |
|
Simulations Plus (SLP) |
0.13 |
0.19 |
18.4M |
17.97M |
361.63M |
AMC |
Market
News:
Here are some of the biggest premarket US stock movers today:
Toll
Brothers Inc. (TOL) announced that Chairman and Chief
Executive Officer Douglas C. Yearley Jr. will
transition to Executive Chairman on March 30, 2026. Karl K. Mistry,
Executive Vice President, will succeed Yearley as CEO
and join the board of directors on the same date.
Jasper
Therapeutics Inc. (JSPR) appointed Jeet
Mahal as president and chief executive officer,
effective January 5. Mahal succeeds Ronald Martell,
who stepped down after serving as CEO since 2022.
Jefferies
Financial Group Inc (NYSE:JEF) Inc reported fourth-quarter earnings
that fell short of analyst expectations on Wednesday, despite posting strong
investment banking revenue growth as dealmaking
activity rebounded across Wall Street.
Lockheed
Martin (LMT) delivered 191 F-35 Lightning II aircraft in 2025, exceeding
the previous record of 142 jets, according to a company statement.
Phathom Pharmaceuticals Inc (NASDAQ:PHAT) stock tumbled
11.7% in after-hours trading Wednesday after the gastrointestinal disease
treatment developer announced plans for a public offering of common stock and
pre-funded warrants.
Kura Sushi
USA, Inc. (NASDAQ:KRUS) reported a wider-than-expected loss for
its fiscal first quarter ended November 30, 2025, despite slightly exceeding
revenue expectations.
Immuneering Corporation (IMRX) reported that 64% of first-line
pancreatic cancer patients treated with its experimental drug atebimetinib combined with modified gemcitabine/nab-paclitaxel survived at 12 months in a Phase 2a clinical
trial.
For internal use only